Quick Answer
Pediatrix Medical Group, Inc. reported Operating Income of $208.81 million for fiscal year 2025.
Pediatrix Medical Group, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | $208.81M | +403.9% |
| 2024 | -$68.71M | -1038.6% |
| 2023 | $7.32M | -95.8% |
| 2022 | $172.69M | -14.9% |
| 2021 | $202.92M | +106.8% |
| 2020 | $98.13M | -42.9% |
| 2019 | $171.76M | -30.9% |
| 2018 | $248.39M | -45.4% |
| 2017 | $454.89M | -20.4% |
| 2016 | $571.69M | +2.5% |
| 2015 | $557.87M | +8.7% |
| 2014 | $513.00M | +13.5% |
| 2013 | $452.13M | +16.1% |
| 2012 | $389.52M | +9.6% |
| 2011 | $355.39M | +13.6% |
| 2010 | $312.91M | +8.3% |
| 2009 | $288.93M | +19.4% |
| 2008 | $242.03M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $68.05M | +101.2% | +13.7% |
| June 30, 2025 | $59.87M | +138.0% | +86.5% |
| March 31, 2025 | $32.10M | +102.0% | -5.1% |
| September 30, 2024 | $33.83M | -16.0% | +121.4% |
| June 30, 2024 | -$157.72M | -425.2% | -1092.5% |
| March 31, 2024 | $15.89M | -47.1% | -60.5% |
| September 30, 2023 | $40.27M | -15.0% | -17.0% |
| June 30, 2023 | $48.50M | -3.3% | +61.4% |
- Pediatrix Medical Group, Inc. showed an increase of +403.9% in Operating Income compared to the prior fiscal year.
- Over the 2008–2025 period, Pediatrix Medical Group, Inc.’s operating income has declined by 13.7% (from $242.03 million to $208.81 million).
- The most recent figure is from Pediatrix Medical Group, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: